Noida, Uttar Pradesh, India, October 2025 — Rishi Kapoor has joined Biodeal Pharmaceuticals Limited as Chief Financial and Business Officer (CFBO), bringing with him over 20 years of strategic financial leadership across the pharma & healthcare, EdTech, IT, and retail sectors. In his new role, Rishi will lead Biodeal’s financial strategy, digital process automation, and IPO readiness initiatives, strengthehttps://biodealpharma.com/ning the company’s growth and operational excellence agenda.
Rishi’s distinguished career reflects a blend of financial expertise and trahttps://biodealpharma.com/nsformative business leadership. Prior to joining Biodeal, he served as Chief Revenue Officer at CollegeDekho, where he successfully scaled the company’s revenue model, streamlined B2B and B2C operations, and contributed to CollegeDekho’s position as one of India’s leading education technology platforms.
Before that, he was Head of Finance at Corbus, LLC, a global technology and supply chain solutions company, where he led financial planning, corporate FP&A, and compliance across international operations. Earlier, at Amrapali Group, he held the role of Group Financial Controller, overseeing financial consolidation, audit processes, and strategic planning for multiple business verticals.
Rishi’s early career was rooted in finance leadership positions with Future Group, Max Healthcare, and EY, where he developed deep capabilities in fundraising, M&A, investor relations, IPO management, and tax compliance. A Chartered Accountant, with a Master’s in Finance and credentials as a Lifetime Certified Independent Director, Rishi has been recognized among India’s Top 10 Most Dynamic Revenue and Growth Leaders 2025 for his outstanding contributions to financial transformation and business growth.
At Biodeal, his appointment comes at a crucial juncture as the company accelerates its IPO journey and strengthens its strategic and financial foundations. Rishi’s visionary approach, coupled with his hands-on leadership style, is expected to drive sustainable expansion and organizational agility for Biodeal Pharmaceuticals.
About Biodeal Pharmaceuticals Limited
Biodeal Pharmaceuticals Limited is a leading Contract Development and Manufacturing Organization (CDMO) in India, serving over 600 clients globally. With WHO-GMP and PIC/S-certified facilities located in Nalagarh, Himachal Pradesh, Biodeal provides comprehensive pharmaceutical development and manufacturing solutions that meet the highest international quality standards.
As a trusted partner to global pharmaceutical innovators, Biodeal continues to expand its footprint through innovation, operational excellence, and a commitment to delivering reliable, high-quality products to healthcare markets worldwide.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
